The NARAL' Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC:A Clinical Trial by the Danish Lung Cancer Group

Autor: Sloth Møller, Ditte, Andersen, Jon L, Appelt, Ane L, Brink, Carsten, Hansen, Olfred, Hoffmann, Lone, Jensen, Nikolaj K G, Josipovic, Mirjana, Khalil, Azza Ahmed, Marquard Knap, Marianne, Lund, Mikkel D, Lutz, Christina Maria, Nielsen, Martin Skovmos, Kunwald Nielsen, Svetlana, Nielsen, Tine B, Nyhus, Christina H, Ottoson, Wiviann, Persson, Gitte F, Sibolt, Patrik, Wedervang, Kim, Schytte, Tine
Jazyk: angličtina
Rok vydání: 2015
Zdroj: Sloth Møller, D, Andersen, J L, Appelt, A L, Brink, C, Hansen, O, Hoffmann, L, Jensen, N K G, Josipovic, M, Khalil, A A, Marquard Knap, M, Lund, M D, Lutz, C M, Nielsen, M S, Kunwald Nielsen, S, Nielsen, T B, Nyhus, C H, Ottoson, W, Persson, G F, Sibolt, P, Wedervang, K & Schytte, T 2015, ' The NARAL" Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC : A Clinical Trial by the Danish Lung Cancer Group ', Journal of Thoracic Oncology, vol. 10, no. 9, Suppl. 2, pp. S286-5287 . https://doi.org/10.1016/S1556-0864(16)30011-9
Databáze: OpenAIRE